Compare Laboratorios Farmaceúticos Rovi SA with Similar Stocks
Dashboard
1
With ROE of 21.13%, it has a Very Expensive valuation with a 6.09 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 51.88%, its profits have risen by 2.6% ; the PEG ratio of the company is 11.2
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
25.84%
0%
25.84%
6 Months
40.77%
0%
40.77%
1 Year
51.88%
0%
51.88%
2 Years
-2.17%
0%
-2.17%
3 Years
101.79%
0%
101.79%
4 Years
15.52%
0%
15.52%
5 Years
63.69%
0%
63.69%
Laboratorios Farmaceúticos Rovi SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
12.10%
EBIT Growth (5y)
18.67%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0.12
Net Debt to Equity (avg)
0.13
Sales to Capital Employed (avg)
1.34
Tax Ratio
22.85%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
36.67%
ROE (avg)
28.59%
Valuation key factors
Factor
Value
P/E Ratio
29
Industry P/E
Price to Book Value
6.09
EV to EBIT
23.46
EV to EBITDA
19.96
EV to Capital Employed
5.98
EV to Sales
5.46
PEG Ratio
11.18
Dividend Yield
124.79%
ROCE (Latest)
25.50%
ROE (Latest)
21.13%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
218.40
199.10
9.69%
Operating Profit (PBDIT) excl Other Income
63.10
39.80
58.54%
Interest
0.80
0.70
14.29%
Exceptional Items
0.00
0.00
Consolidate Net Profit
42.70
23.40
82.48%
Operating Profit Margin (Excl OI)
251.50%
162.50%
8.90%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is 9.69% vs -15.13% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is 82.48% vs -54.56% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
743.50
763.70
-2.65%
Operating Profit (PBDIT) excl Other Income
203.50
206.70
-1.55%
Interest
2.80
2.40
16.67%
Exceptional Items
-0.10
0.00
Consolidate Net Profit
140.40
136.90
2.56%
Operating Profit Margin (Excl OI)
232.90%
234.00%
-0.11%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -2.65% vs -7.93% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 2.56% vs -19.61% in Dec 2024
About Laboratorios Farmaceúticos Rovi SA 
Laboratorios Farmaceúticos Rovi SA
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






